Headache
Conditions
Keywords
posture, sit
Brief summary
Diagnosing and treating posture-related headache (PRH), such as tension-type and cervicogenic headache, is seriously hampered because of common features and complex interaction of the neurological and musculoskeletal system. Current therapies are therefore not as effective and the population of patients with PRH keeps on increasing. The diagnostic as well as the therapeutic process need more structure in order to select the most effective treatment; thereby contributing to preventive measures. This goal can be achieved through fundamental research with a clinically oriented background. Our study starts from a clinical problem, with a growing incidence, and is therefore highly relevant. Because sitting-posture seems to play an important role in PRH, the first step in the diagnostic process is to analyse postural differences between a PRH- and a control-group. In addition, the role of the dura mater in the headache-process will be examined. Patients with PRH will be classified in homogeneous groups based on these results. In a second phase individual-specific treatment programs will be composed. The general treatment-approach of postural abnormalities in the past failed because of the heterogeneous patient-populations. Sub-classifying musculoskeletal problems has been proven to be successful in the past (O'Sullivan & Dankaerts, non-specific low back pain). Our study is divided in 2 phases: * phase 1: profile analysis (no intervention, experimental headache-group vs. asymptomatic controls) * phase 2: interventional phase (clustered headache-groups, based on the results of phase 1
Interventions
OTHERIndividual Profile Analysis (Physical therapy Intervention)
The Individual Profile Analysis consists of the following components: * Analysis of the sitting-posture profile: o cervical spine, thoracic spine, lumbar spine and pelvis during a longitudinal provoking task (working at a laptop). * Analysis of the dural profile before and after the provoking task: o Determination of the dural sensitivity by the use of the slump-test * Analysis of the pain profile before and after the provoking task: * Determination of pressure pain sensitivity by the use of pressure algometry * Determination of the influence of pain on the quality of life by the use of the HIT-6 questionnaire
Sponsors
KU Leuven
Ziekenhuis Oost-Limburg
Jessa Hospital
Orbisch Medisch Centrum
Zuyd University of Applied Sciences
Algemeen Ziekenhuis Vesalius
Hasselt University
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
Headache-group: 1. Males and females between 20 and 50 years 2. Confirmed medical diagnosis of tension-type headache, cervicogenic headache or a mixture 3. Headache can be provoked by awkward cervical and/or head postures
Exclusion criteria
Headache-group: 1. Pregnancy 2. History of pericranial surgery 3. Serious pathology (neurological/cardiovascular/endocrine/musculoskeletal) 4. Red flags 5. Physical or manual therapy treatment for headache \< 4 weeks prior the study 6. Excessive (\> 10 days/month for \> 3 months) use of: ergotamine, NSAID's, opioids, triptans, acetylsalicylic acid and simple analgesics 7. Psychiatric comorbidity 8. Visual or temporo-mandibular dysfunction Inclusion Criteria Control-group: 1. Males and females between 20 and 50 years 2. Asymptomatic, no headache-history
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sitting-posture-profile | day 1 | Sitting-posture will be measured with a 3D-video analysis (Bonita, ©Vicon Motion Systems Ltd. UK). Markers are placed on specific anatomical reference points on the participant. Afterwards angles (°) will be automatically calculated (Nexus, ©Vicon Motion Systems Ltd. UK) |
| Pain-Profile | day 1 | 'Pain Pressure Threshold' will be measured. Through pressure- algometry (a) 'Pressure Pain Detection Threshold' (kPa/cm²) and (b) 'Pressure Pain Tolerance' (sec) will be determined (Somedic Sales AB, Stockholm Sweden). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Headache-related medication-use, headache intensity, duration and frequency. | week -4 up to week 8 | Through the use of a specific diary the secondary outcomes will be evaluated. |
| Impact of headache on the quality of life. | week -4 up to week 8 | The 'Headache Impact Test (HIT-6)' will be used. |
Countries
Belgium, Netherlands
Outcome results
None listed